Ascletis Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019 - 2016
Period Ending	Dec '25 Dec 4, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019 - 2016
Market Capitalization	13,540	2,904	1,522	5,153	3,575	3,154	Upgrade
Market Cap Growth	823.15%	90.74%	-70.46%	44.13%	13.38%	-4.03%	Upgrade
Enterprise Value	11,572	665	-1,197	2,236	435	-134	Upgrade
Last Close Price	13.65	3.01	1.46	4.74	3.29	2.87	Upgrade
PS Ratio	5227.12	2126.81	24.42	84.27	37.89	75.87	Upgrade
PB Ratio	6.62	1.39	0.59	1.80	1.07	0.89	Upgrade
P/TBV Ratio	6.65	1.40	0.60	1.81	1.10	0.92	Upgrade
EV/Sales Ratio	-	486.91	-	36.57	4.61	-	Upgrade
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.00	Upgrade
Asset Turnover	0.00	0.00	0.02	0.02	0.03	0.01	Upgrade
Inventory Turnover	0.27	0.11	2.30	2.05	0.66	1.02	Upgrade
Quick Ratio	14.52	12.82	16.50	23.24	28.26	37.47	Upgrade
Current Ratio	14.57	12.88	16.58	23.52	28.93	38.36	Upgrade
Return on Equity (ROE)	-12.78%	-13.97%	-5.93%	-11.95%	-6.97%	-6.64%	Upgrade
Return on Assets (ROA)	-12.32%	-10.96%	-7.50%	-7.94%	-4.88%	-4.79%	Upgrade
Return on Capital (ROIC)	-12.96%	-11.70%	-7.89%	-8.26%	-5.04%	-4.93%	Upgrade
Return on Capital Employed (ROCE)	-22.50%	-20.50%	-13.10%	-13.70%	-8.40%	-8.30%	Upgrade
Earnings Yield	-2.09%	-11.03%	-10.47%	-6.91%	-6.83%	-7.88%	Upgrade
FCF Yield	-2.53%	-12.60%	-16.64%	-4.60%	-5.21%	-3.38%	Upgrade
Buyback Yield / Dilution	6.18%	6.75%	1.19%	0.96%	-5.53%	1.37%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.